Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00305955 · ClinicalTrials.gov registry record
Bilateral Refractive Amblyopia Treatment Study
A clinical trial, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- 113
- Enrollment target
NCT00305955: Completed study, sponsored by Jaeb Center for Health Research.
NCT00305955 is a clinical trial that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 113 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00305955 has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- 113 participants
- Enrollment target
Study Summary
The purpose of this study will be to: * Determine the amount of visual acuity improvement with treatment of presumed bilateral refractive amblyopia * Determine the time course of visual acuity improvement with treatment
Interventions
- DEVICE Spectacles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2004-08 |
| Est. Completion | 2006-10 |
What the finished NCT00305955 record still lists
NCT00305955 is an observational study that tracks outcomes without assigning an intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Spectacles is the first listed.
NCT00305955 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00305955 about?
NCT00305955 is a clinical study titled "Bilateral Refractive Amblyopia Treatment Study". The purpose of this study will be to: * Determine the amount of visual acuity improvement with treatment of presumed bilateral refractive amblyopia * Determine the time course of visual acuity improvement with treatment
What is the current status of trial NCT00305955?
This trial is currently completed. The enrollment target is 113 participants. The study started on 2004-08. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00305955?
The interventions under investigation include: Spectacles (DEVICE).
Who is sponsoring clinical trial NCT00305955?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00748254 · 113 participants
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
- NCT04753190 · 113 participants · NA
Light Timing Study
- NCT05799248 · 113 participants · Phase 3
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
- NCT07216105 · 113 participants · Phase 1
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia